NFE2L2 and cancer: Specifically, NFE2L2 expression was higher in tissues from 7 cancers (CHOL, ESCA, GBM, LGG, LUSC, PAAD, and STAD) and lower in tissues from 15 cancers (ACC, BLCA, BRCA, KIRC, KIRP, LAML, LUAD, OV, PRAD, READ, SKCM, TGCT, THCA, UCEC, and UCS) than in the normal tissues (Figure 1(d)).